MMAE-SMCC is an antibody-drug conjugate (ADC) linker-payload compound that combines a monomethyl auristatin E (MMAE) cytotoxic agent with a SMCC crosslinker. It is designed for use in the development of targeted cancer therapies by enabling the conjugation of a potent drug to an antibody.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing MMAE-SMCC?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
5-Amino-N,N'-bis(2,3-dihydroxypropyl)isophthalamide
research compound
7H-Benzo[c]carbazole
possibly carcinogenic research substance
Palmitoyl pentapeptide-4
anti-wrinkle cosmetic active ingredient
N'-(1,3-dimethylbutylidene)-3-hydroxy-2-naphthohydrazide
Hydrazide derivative for research
(2,5-dioxopyrrolidin-1-yl) 4-[[3-[3-[[(2S)-1-[[(2S)-1-[[(3R,4S,5S)-1-[(2S)-2-[(1R,2R)-3-[[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]amino]-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl]-3-methoxy-5-methyl-1-oxoheptan-4-yl]-methylamino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-methylamino]-3-oxopropyl]sulfanyl-2,5-dioxopyrrolidin-1-yl]methyl]cyclohexane-1-carboxylate
KPJLIFRLZIUVFO-AREODUGYSA-N
CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@@H]([C@@H](C)C(=O)N[C@H](C)[C@H](C2=CC=CC=C2)O)OC)OC)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)N(C)C(=O)CCSC3CC(=O)N(C3=O)CC4CCC(CC4)C(=O)ON5C(=O)CCC5=O
Sourcing MMAE-SMCC?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.